Theophylline
- Product NDC
- 29033-002
- 11-digit product format
- 290330002
- Labeler code
- 29033
- Product ID
- 29033-002_cc6d208a-826c-4aae-a78e-da1a91c60699
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Theophylline
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Nostrum Laboratories, Inc.
- Application
- ANDA040560
- Marketing category
- ANDA
- Marketing start
- 2020-01-23
- Marketing end
- 0000-00-00
- Substance
- THEOPHYLLINE ANHYDROUS
- Active strength
- 600 mg/1
- Pharmacologic classes
- Methylxanthine [EPC],Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1d07c79-5983-427d-b6f5-df0550dcc598 | Product name | 4 | 20250325 |
| 7b1e3dc0-e6b1-4d5d-943b-99fdd948b5a2 | Product name | 1 | 20170302 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 29033-002-01 | 2026-01-29 | C162847 | 48780-1 | 49896155-bf89-586f-e063-e6dba90add90 | Theophylline (Anhydrous) Extended-Release Tablets 400 mg and 600 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29033-002-01 | Theophylline(Anhydrous) | 100 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 100 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 29033-002-01 | EA - Each | 29033-002 | bdf67cde-4ddb-49e8-925e-0b2e7ebd8c9f | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| THEOPHYLLINE ANHYDROUS | ACTIVE INGREDIENT | 0I55128JYK | THEOPHYLLINE (ANHYDROUS) (THEOPHYLLINE) TABLET, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 2 | |
| THEOPHYLLINE ANHYDROUS | ACTIVE INGREDIENT | 0I55128JYK | THEOPHYLLINE (ANHYDROUS) (THEOPHYLLINE) TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| THEOPHYLLINE ANHYDROUS | ACTIVE MOIETY | 0I55128JYK | THEOPHYLLINE (ANHYDROUS) (THEOPHYLLINE) TABLET, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.] | 2 | |
| THEOPHYLLINE ANHYDROUS | ACTIVE MOIETY | 0I55128JYK | THEOPHYLLINE (ANHYDROUS) (THEOPHYLLINE) TABLET, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313291 | theophylline 400 MG Extended Release Oral Tablet | PSN | 038c2b07-8028-4dc4-847c-adafe1b0e81a | 6 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | PSN | 038c2b07-8028-4dc4-847c-adafe1b0e81a | 6 |
| 313291 | theophylline 400 MG Extended Release Oral Tablet | SCD | 038c2b07-8028-4dc4-847c-adafe1b0e81a | 6 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | SCD | 038c2b07-8028-4dc4-847c-adafe1b0e81a | 6 |
| 313291 | theophylline 400 MG Extended Release Oral Tablet | PSN | aa80b9f4-8a5d-3e14-e053-2a95a90a8aab | 5 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | PSN | aa80b9f4-8a5d-3e14-e053-2a95a90a8aab | 5 |
| 313291 | theophylline 400 MG Extended Release Oral Tablet | SCD | aa80b9f4-8a5d-3e14-e053-2a95a90a8aab | 5 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | SCD | aa80b9f4-8a5d-3e14-e053-2a95a90a8aab | 5 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | PSN | c88d2f3e-3478-4ed4-b4da-44dece7818e9 | 3 |
| 348472 | theophylline 600 MG Extended Release Oral Tablet | SCD | c88d2f3e-3478-4ed4-b4da-44dece7818e9 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 29033-002-01 | 29033000201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29033-002-01) | 2020-01-23 | 0000-00-00 | No | No | Current |